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Global reduction in insulin signaling has been linked to extended life span in a range of organisms.
Newwork onmice with brain-specific or whole-body reductions in insulin receptor substrate 2 (IRS2)
(Taguchi et al., 2007) points to a role for insulin/IGF-1 signaling in the central control of mammalian
aging.Cell Metabolism 6, September 2007 ª2007 Elsevier Inc. 153Studies of mutant, gene knockout, and
transgenic mice have provided con-
siderable evidence that growth hor-
mone (GH), insulin-like growth factor
1 (IGF-1; a key mediator of GH action),
and insulin are involved in the control
of aging and longevity in mammals.
Most intriguingly, homologous (IGF/
insulin) signaling pathways play a cru-
cial role in the control of longevity in
a microscopic worm, Caenorhabditis
elegans, and in a fruit fly, Drosophila
melanogaster. In each of these organ-
isms, suppression (but not complete
blockade!) of the insulin, IGF, or insu-
lin/IGF-like signaling can delay aging
and increase life span. Although these
hormones can influence most cells
and organs, their effects on longevity
may result from targeting of specific
sites. For example, in C. elegans and
Drosophila, downregulation of insulin
signaling or overexpression of genes
related to antioxidant defenses selec-
tively in the nervous system can ex-
tend life. In mice, deletion of insulin
receptors in adipose tissue increases
average life span by approximately
18% (Blu¨her et al., 2003). In a recent
paper Taguchi, Wartschow, and White
report that deletion of insulin receptor
substrate 2 (IRS2) in the brain of mice
increases their longevity (Taguchi
et al., 2007). These exciting findings
suggest that the central nervous sys-
tem (CNS) is involved in the control of
life span in mammals and that sys-
temic consequences of the local ac-
tions of insulin and IGF-1 within the
brain include effects on aging and lon-
gevity of the whole organism. The re-
sults also suggest that reduced IRS2
signaling in the CNS may contribute
to the increased longevity of micewith mutations of various growth
hormone (GH), IGF-1, or insulin-re-
lated genes (Bartke et al., 2004; Bartke
and Brown-Borg, 2004). Phosphoryla-
tion of IRS2 by activated insulin and
IGF-1 receptors represents one of the
early steps in the cellular pathway of
signaling by these hormones.
Mice heterozygous for the brain
IRS2 knockout (bIrs2+/) lived approx-
imately 18% longer than wild-type an-
imals, an effect almost identical to life
span extension in Irs2+/ mice with
systemic (whole-animal) reduction in
IRS2 signaling. Homozygous deletion
of the Irs2 gene in the whole animal
produced early lethality, but brain-
specific IRS2-deleted (bIrs2/) mice
lived 14% longer than normal controls.
Many control (loxP-flanked Irs2; flrs2)
mice died relatively early (between
the ages of 400 and 700 days); no in-
formation was provided on the cause
of death in these or in IRS2-deleted an-
imals. Yet the median life span of flrs2
animals was nearly identical to the
values measured in wild-type mice in
the study of systemic IRS2 deletion in
which there was very little early mortal-
ity. Studies of various age-sensitive
traits in flrs2, bIrs2+/, and bIrs2/
mice suggested that reduction of
IRS2 signaling in the brain leads to
a delay in aging and maintenance of
more ‘‘youthful’’ characteristics until
the age of 22 months. These observa-
tions strengthen the study and suggest
that differences in median longevity
were likely related to effects on the
biological process of aging rather than
to reduction or elimination of disease
during the second year of life.
Some of the phenotypic characteris-
tics of bIrs2/ and bIrs2+/mice wereunexpected and raise interesting
questions about the mechanisms of
extended longevity of these as well
as other mutant mice. Brain IRS2-
deleted, long-lived mice were insulin
resistant and became hyperinsuline-
mic as they aged. This contrasts with
the consequences of whole-animal
reduction in IRS2 signaling in Irs2+/
mice in which sensitivity to insulin
was increased and also with findings
that long-lived hypopituitary, GH-
deficient and GH-resistant mice are
hypoinsulinemic and insulin sensitive
(Bartke et al., 2004; Bartke and Brown-
Borg, 2004; Dominici et al., 2002;
Berryman et al., 2006). Sensitivity to
IGF-1 (which, like insulin, can signal
via IRS1 and IRS2) was not evaluated
in Irs2+/, bIrs2+/, or bIrs2/ mice
or in other long-lived mutants.
Association of insulin resistance
with an increase in longevity is surpris-
ing. With the exception of transgenic
Klotho mice (Kurosu et al., 2005), there
is little precedent for such association
or, for that matter, for any beneficial ef-
fects of insulin resistance. In contrast,
enhanced insulin sensitivity is believed
to represent an important mechanism
of increased longevity in long-lived
mutant mice (Bartke et al., 2004;
Bartke and Brown-Borg, 2004), in ge-
netically normal (wild-type) animals
subjected to calorie restriction, and in
exceptionally long-lived people (Pao-
lisso et al., 1996).
How can this apparent paradox be
explained? In both sexes of bIrs/
mice, the calculated (homeostasis
model assessment; HOMA) index of
insulin sensitivity was reduced and
glucose resistance was increased at
2 months of age, but these differences
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During the same period, insulin sensi-
tivity declined in control mice. Perhaps
protection from age-related deterio-
ration of insulin sensitivity can com-
pensate for the presumably harmful
consequences of insulin resistance
during early adulthood. However, this
hypothetical explanation does not fit
the data obtained in male bIrs+/
mice. As suggested by the authors,
IRS2 deletion in the brain may shield
it from the presumably deleterious ef-
fects of age-related hyperinsulinemia.
Another possible reason for the un-
expected association of insulin resis-
tance and increased longevity in brain
IRS2-deleted mice is the composition
of the food used in the study, de-
scribed as a ‘‘high-energy diet’’ con-
taining 9% fat, rather than the custom-
ary fat content of 4.5%–6.5% in both
‘‘maintenance’’ and ‘‘breeder’’ diets
used in other studies of aging in
mice. Perhaps in animals fed a diet
that can be expected to promote obe-
sity and hyperinsulinemia, mild insulin
resistance is beneficial because it re-
duces the strength of the insulin signal.
Extension of life span in bIrs2+/ and
bIrs2/ mice fed a high energy diet
could also be related to the presum-
ably reduced action of IGF-1. Levels of
IGF-1 normally increase in response to
nutritional signals, and reduced IGF-1
levels are strongly associated with
increased longevity in GH-deficient154 Cell Metabolism 6, September 2007and GH-resistant mice. Moreover, re-
duced sensitivity to IGF-1 is associ-
ated with a significant increase of life
span in female Igf1r+/ mice (Holzen-
berger et al., 2003), and reduction of
free (bioavailable) IGF-1 was recently
reported to lead to extension of life in
pregnancy-associated plasma protein
A (PAPP-A) knockout mice (Conover
and Bale, 2007). It would certainly be
of great interest to determine if mice
with reduced brain IRS2 signaling live
longer than controls when they con-
sume a diet with a lower percentage
of fat.
Coexistence of increased adiposity
and extended life span in bIrs2+/
and bIrs2/ mice may seem surpris-
ing but agrees with the observations
in GH-resistant and GH-deficient mu-
tants (Bartke and Brown-Borg, 2004;
Berryman et al., 2006). However, re-
duction of brain weight in these long-
lived animals is unexpected. In various
mutant and transgenic mice, in ani-
mals subjected to CR, and in interspe-
cies comparisons, extended longevity
correlates with an increase rather
than a reduction in relative brain
weight. It would be exciting to know
whether cognitive function was af-
fected by deletion of IRS2 in the brain.
The results reported by Taguchi
et al. (2007) raise an important issue
of the role of insulin/IGF-1 signaling in
the brain in the control of mammalian
aging but, as is often the case withª2007 Elsevier Inc.novel and exciting findings, also
prompt many new questions that
remain to be answered.
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